Insider Transactions in Q3 2023 at C4 Therapeutics, Inc. (CCCC)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Kendra Adams Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+34.9%
|
-
|
|
Aug 30
2023
|
Scott N Boyle Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
661
-2.41%
|
$1,322
$2.93 P/Share
|
|
Aug 30
2023
|
Scott N Boyle Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+7.58%
|
-
|
|
Aug 30
2023
|
Stewart Fisher Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
661
-0.63%
|
$1,322
$2.93 P/Share
|
|
Aug 30
2023
|
Stewart Fisher Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+2.1%
|
-
|
|
Aug 30
2023
|
Kelly Schick Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
661
-2.42%
|
$1,322
$2.93 P/Share
|
|
Aug 30
2023
|
Kelly Schick Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+7.6%
|
-
|
|
Aug 30
2023
|
Lauren White Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
661
-1.98%
|
$1,322
$2.93 P/Share
|
|
Aug 30
2023
|
Lauren White Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+6.32%
|
-
|
|
Aug 30
2023
|
Jolie Siegel Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
661
-2.42%
|
$1,322
$2.93 P/Share
|
|
Aug 30
2023
|
Jolie Siegel Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+7.6%
|
-
|
|
Aug 30
2023
|
Andrew Hirsch President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,205
-1.9%
|
$4,410
$2.93 P/Share
|
|
Aug 30
2023
|
Andrew Hirsch President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+6.07%
|
-
|
|
Jul 10
2023
|
Leonard Reyno Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,300
+50.0%
|
-
|
|
Jul 03
2023
|
Glenn Dubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,887
+23.63%
|
$7,774
$2.83 P/Share
|
|
Jul 03
2023
|
Kenneth Carl Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,976
+3.73%
|
$7,952
$2.83 P/Share
|
|
Jul 03
2023
|
Donna Roy Grogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,858
+29.27%
|
$9,716
$2.83 P/Share
|